Product image of Medrol (Methylprednisolone) supplied by GNH India

Medrol

Active Ingredient:
Methylprednisolone
Origin:
EU

Medrol (Methylprednisolone)

Methylprednisolone, the active ingredient in Medrol, is a glucocorticoid presented as an oral tablet for oral use. It is employed to reduce inflammation and suppress immune responses in a variety of acute and chronic conditions.

GNH India supplies Medrol as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Pfizer Ab

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Methylprednisolone is a systemic corticosteroid used to manage inflammatory and immune‑mediated disorders.

  • Rheumatoid arthritis: reduces joint inflammation and pain.
  • Severe asthma: decreases airway swelling and improves breathing.
  • Acute allergic reactions: mitigates swelling, hives, and airway compromise.
  • Dermatologic inflammatory conditions: eases redness and itching in eczema or psoriasis.
  • Inflammatory bowel disease: controls flare‑ups of Crohn’s disease or ulcerative colitis.

How It Works

  • Methylprednisolone binds to intracellular glucocorticoid receptors, forming a complex that translocates to the nucleus and alters gene transcription. This results in decreased production of pro‑inflammatory cytokines, inhibition of leukocyte migration, and suppression of immune cell activation, thereby reducing inflammation and immune responses.

Side Effects

Methylprednisolone may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects

  • Increased appetite and weight gain.
  • Insomnia or difficulty sleeping.
  • Mood swings or irritability.
  • Elevated blood glucose levels.
  • Gastrointestinal discomfort or nausea.
  • Facial flushing or acne.

Serious or Rare Side Effects

  • Adrenal insufficiency on abrupt discontinuation.
  • Severe infections due to immune suppression.
  • Osteoporosis and increased fracture risk.
  • Psychosis or severe mood disturbances.
  • Cushingoid appearance (moon face, central obesity).
  • Anaphylaxis or severe allergic reaction.

Precautions & Warnings

Before initiating therapy, consider the following precautions.

  • Infection risk: assess for active infections and avoid use in uncontrolled systemic fungal disease.
  • Blood glucose monitoring: patients with diabetes may require dose adjustments.
  • Bone health: evaluate risk of osteoporosis, especially with long‑term use.
  • Tapering: gradually reduce dose after prolonged therapy to prevent adrenal crisis.
  • Cardiovascular: monitor blood pressure in patients with hypertension.
  • Store at ambient temperature: keep in the original container, protect from moisture and heat.

Avoid Interactions

Methylprednisolone can interact with several drug classes; awareness helps prevent adverse outcomes.

Major Interactions (Avoid)

  • Strong CYP3A4 inhibitors (e.g., ketoconazole): may increase corticosteroid levels.
  • Live vaccines: risk of vaccine‑derived infection due to immunosuppression.
  • Anticoagulants (e.g., warfarin): enhanced anticoagulant effect, increasing bleeding risk.

Moderate Interactions (Monitor Closely)

  • Non‑steroidal anti‑inflammatory drugs (NSAIDs): additive risk of gastrointestinal ulceration.
  • Diabetic agents (insulin, oral hypoglycemics): may require dose adjustment due to hyperglycemia.
  • Antihypertensives: corticosteroids can blunt blood‑pressure‑lowering effects.

Frequently Asked Questions

Medrol, containing methylprednisolone, is prescribed for inflammatory and immune‑mediated conditions such as rheumatoid arthritis, severe asthma, acute allergic reactions, certain skin disorders, and inflammatory bowel disease. The specific indication depends on the patient’s diagnosis and the prescribing physician’s assessment.

Methylprednisolone binds to glucocorticoid receptors inside cells, altering gene expression. This reduces the production of inflammatory cytokines, limits immune cell activation, and stabilizes cell membranes, leading to decreased inflammation and immune response across multiple organ systems.

The dosage of Medrol is individualized by the prescribing clinician based on the condition being treated, severity, patient weight, and response. Dosage regimens can range from short‑term high‑dose courses to low‑dose maintenance therapy, and must follow the prescriber’s instructions.

Safety of methylprednisolone in pregnancy or lactation should be evaluated by a healthcare professional. While corticosteroids cross the placenta and may be present in breast milk, benefits may outweigh risks in certain conditions, but the decision must be made by the treating physician.

To request Medrol, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Medrol (methylprednisolone) is a medium‑to‑high potency oral glucocorticoid. Compared with prednisone, it has a slightly higher anti‑inflammatory potency and a shorter biological half‑life, allowing more flexible dosing. Choice of agent depends on clinical goals, dosing convenience and physician preference.

Medrol tablets should be stored at ambient temperature, below 25 °C (77 °F). Keep them in the original packaging, protect from moisture and direct sunlight, and ensure the container is tightly closed to maintain product stability.

Medrol is taken orally, usually with food or a glass of water to reduce stomach irritation. The exact dosing schedule—once daily, divided doses, or tapering—must follow the prescribing clinician’s directions.

Serious risks include adrenal suppression, severe infections, osteoporosis, hyperglycemia, and psychiatric effects such as mood swings or psychosis. Patients should be monitored regularly, and any signs of infection, bone pain, or mood changes should be reported promptly.

Medrol is contraindicated in patients with known hypersensitivity to methylprednisolone or any component of the formulation, and in those with active systemic fungal infections. Caution is also advised for individuals with uncontrolled diabetes, severe hypertension, or a history of peptic ulcer disease.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Methylprednisolone

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT